Study links aspirin with lower melanoma risk

03/12/2013 | SkinAndAllergyNews.com

Postmenopausal women who take aspirin regularly might have a lower risk of melanoma, researchers analyzing data from the Women's Health Initiative report in the journal Cancer. The protective effect appeared to grow stronger with increased duration, and a similar association was not seen with other NSAIDs. The findings were consistent with studies of aspirin and other cancers, including colorectal malignancies, dermatologist Jean Tang and fellow researchers said.

View Full Article in:

SkinAndAllergyNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI